Drugs and Devices

FDA approves first anti-diarrheal drug for HIV/AIDS patients

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy; it is the first FDA-approved therapy for the indication. Derived from the red sap of the Croton lechleri plant, Fulyzaq is the second botanical prescription drug approved by FDA. Read more.

Related Articles:

Leave a Reply

You have to agree to the comment policy.